Daré Bioscience, Inc. (DARE) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Daré Bioscience, Inc. (DARE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $22.2M, listed on NASDAQ, employing roughly 21 people, carrying a beta of 1.09 to the broader market. Daré Bioscience, Inc. Led by Sabrina Martucci Johnson, public since 2014-04-10.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for DARE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →